Sanofi to pay Regeneron $462 million in revised immuno-oncology deal Farhat Nasim9 Jan 2019 9:15 AM ISTSanofi will pay Regeneron $462 million representing the balance of payments due under their original deal, which covers the Sanofi share of the...
Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales Ruby Khatun Khatun11 Nov 2017 9:30 AM ISTRegeneron Pharmaceuticals Inc on Wednesday reported third-quarter profit that sailed past Wall Street estimates on the strength of increased demand...
New AstraZeneca, Amgen drug looks strong rival in severe asthma Ruby Khatun Khatun11 Sept 2017 10:27 AM ISTLONDON: A new kind of injectable biotech treatment for severe asthma from AstraZeneca and Amgen promises to help a much broader range of patients than...